BIONTECH SE - AMERICAN DEPOSITARY SHARES

Pfizer and BioNTech Announce Submission of Initial Data to U.S. FDA to Support Booster Dose of COVID-19 Vaccine

16 Aug 2021 11:31:14 By Nasdaq GlobeNewswire

BioNTech Announces Second Quarter 2021 Financial Results and Corporate Update

09 Aug 2021 07:00:00 By Nasdaq GlobeNewswire

BioNTech Completes Acquisition of Kite’s Neoantigen TCR Cell Therapy R&D Platform and Manufacturing Facility in Gaithersburg, Maryland

04 Aug 2021 07:00:00 By Nasdaq GlobeNewswire

BioNTech to Report Second Quarter Financial Results and Operational Update on August 9, 2021

02 Aug 2021 07:00:00 By Nasdaq GlobeNewswire

BioNTech Provides Update on Plans to Develop Sustainable Solutions to Address Infectious Diseases on the African Continent

26 Jul 2021 10:00:00 By Nasdaq GlobeNewswire

Fighting Infectious Diseases on the African Continent

23 Jul 2021 09:50:25 By Nasdaq GlobeNewswire

Pfizer And BioNTech to Supply U.S. Government with an Additional 200 Million Doses of COVID-19 Vaccine to Help Meet Continued Need for Vaccine Supply in the U.S.

23 Jul 2021 06:45:00 By Nasdaq GlobeNewswire

Pfizer and BioNTech Announce Collaboration with Biovac to Manufacture and Distribute COVID-19 Vaccine Doses within Africa

21 Jul 2021 07:15:00 By Nasdaq GlobeNewswire

BioNTech to Acquire Kite’s Neoantigen TCR Cell Therapy R&D Platform and Manufacturing Facility in Gaithersburg, MD

19 Jul 2021 08:00:00 By Nasdaq GlobeNewswire

BioNTech Announces First Patient Dosed in Phase 2 Clinical Trial of mRNA-based BNT111 in Patients with Advanced Melanoma

18 Jun 2021 05:00:00 By Nasdaq GlobeNewswire

Pfizer and BioNTech to Provide 500 Million Doses of COVID-19 Vaccine to U.S. Government for Donation to Poorest Nations

10 Jun 2021 02:00:00 By Nasdaq GlobeNewswire

Pfizer and BioNTech Receive First Authorization in European Union for COVID-19 Vaccine in Adolescents

28 May 2021 15:45:00 By Nasdaq GlobeNewswire

BioNTech Publishes First Sustainability Report and Receives “Prime” Rating by ISS ESG

21 May 2021 06:00:00 By Nasdaq GlobeNewswire

Pfizer and BioNTech Sign Agreement for Additional Supply to Turkey of 60 Million Doses of their COVID-19 Vaccine

20 May 2021 06:00:00 By Nasdaq GlobeNewswire

Pfizer and BioNTech to Supply the European Union with up to 1.8 Billion Additional Doses of COMIRNATY®

20 May 2021 05:00:00 By Nasdaq GlobeNewswire

BioNTech Broadens Management Board by Appointing Jens Holstein as CFO

18 May 2021 06:00:00 By Nasdaq GlobeNewswire

Pfizer and BioNTech Receive First U.S. Authorization for Emergency Use of COVID-19 Vaccine in Adolescents

11 May 2021 02:30:00 By Nasdaq GlobeNewswire

BioNTech Announces First Quarter 2021 Financial Results and Corporate Update

10 May 2021 07:00:00 By Nasdaq GlobeNewswire

BioNTech to Establish Regional Headquarters for South East Asia and First mRNA Manufacturing Facility in Singapore

10 May 2021 01:31:52 By Nasdaq GlobeNewswire

Pfizer and BioNTech Initiate Rolling Submission of Biologics License Application for U.S. FDA Approval of their COVID-19 Vaccine

07 May 2021 06:45:00 By Nasdaq GlobeNewswire